Cancer BiologybioRxivPreprint
Data-driven discovery of targets for bipotent anticancer drugs identifies Estrogen Related Receptor Alpha
A. Sahu, X. Wang, P. Munson…·K. Flaherty
BipotentR identifies immune-metabolic regulators for bipotent anticancer drugs, demonstrating ESRRA inhibition's effects on tumor metabolism and immune mechanisms.
DOI 10.1101/2021.10.25.465724